Variant position: 59 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 239 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human PPGAAPAPGIFSSQPGHTPH PAASRDPVARTSPLQTPAAPG
Mouse PLGAAPTPGIFSFQPESNPM PAVHRDMAARTSP---LRPLV
Rat PLRAAPTPGIFSFQPESNRT PAVHRDTAARTSP---LRPLV
Bovine PPGAAPAPGILSSQPGRTPA PS-------RTSP---PPPPA
Dog PLGAAPTPGIFSFQPESNPT PAVHRDMAARTSP---LRPIV
Chicken PVPPAPAPAAAPAAVAAAGA SSHHR-----------PEPPG
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 239 Apoptosis regulator Bcl-2
69 – 69 Phosphothreonine; by MAPK8
70 – 70 Phosphoserine; by MAPK8 and PKC
64 – 64 D -> A. No effect on cleavage by caspase-3.
Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas.
Tanaka S.; Louie D.C.; Kant J.A.; Reed J.C.;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-131 (ISOFORM ALPHA); VARIANTS NON-HODGKIN LYMPHOMA SER-59 AND ILE-93;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.